Melissa Palmer, M.D. is available for consulting to the biotech and pharmaceutical industry, in addition to expert witnessing, on all matters pertaining to liver disease. Areas covered include–
- Drug-induced Liver Injury (DILI) ( Hepatotoxicity)
- NonAlcoholic steatohepatitis (NASH) ( Fatty Liver ) (nonalcoholic fatty liver disease (NAFLD)
- Liver Cancer
- Wilson’s Disease
- Cholestatic Liver Disease ( Primary Biliary Cholangitis (PBC)) Primary Sclerosing Cholangitis (PSC)
- Note* — Consults on patients care will not be provided
About Melissa Palmer, M.D.
Melissa Palmer, MD has been a hepatologist since 1988. She was in a solo practice devoted to treating and evaluating patients with liver disease until 2009 at which time she became Director of Hepatology at NYU Plainview. During that time she served as a consultant to > 15 industry -associated companies as an expert on all aspects of liver disease from drug development to commercialization. Dr. Palmer left NYU to become Senior Vice President of Clinical Research and Head of Hepatology at Kadmon Corporation. After 1 year Dr. Palmer was promoted to Global Head of Hepatology, and became Senior Vice President of Pharmacovigilance in addition to SVP of Clinical Research.
Dr. Palmer left Kadmon in 2015 to join Shire as the Global Clinical Development Lead – Hepatology, to be the clinical lead on their NASH program, as well as to consult on other liver-related issues within the company, such as cholestatic liver disease and liver-related safety issues. After a year and a half she was promoted to interim Global Development Lead – Hepatolgy.
She remains a Clinical Professor of Medicine at NYU.
Dr. Palmer graduated from Columbia University with a B.A. and was trained in hepatology (as well as medical school) at the Mount Sinai School of Medicine in New York City. She has authored numerous medical and lay-public book and book chapters and contributed to three encyclopedias on various liver-related topics. Her scientific publications in the field of Hepatology have appeared in such peer-reviewed journals as Hepatology, Gastroenterology, Seminars of Liver Disease, Transplantation and she is a contributing editor of several peer-reviewed journals.
To request a consult, please send an email to firstname.lastname@example.org